Published in JAMA Pediatr on November 01, 2013
Citalopram for Children With Autism and Repetitive Behavior (STAART Study 1) | NCT00086645
The effect of oxytocin nasal spray on social interaction deficits observed in young children with autism: a randomized clinical crossover trial. Mol Psychiatry (2015) 1.11
The serotonin system in autism spectrum disorder: From biomarker to animal models. Neuroscience (2015) 0.99
Safety and Efficacy of Memantine in Children with Autism: Randomized, Placebo-Controlled Study and Open-Label Extension. J Child Adolesc Psychopharmacol (2016) 0.83
Placebo eff ects in psychiatry: mediators and moderators. Lancet Psychiatry (2015) 0.83
Predictors of placebo response in pharmacological and dietary supplement treatment trials in pediatric autism spectrum disorder: a meta-analysis. Transl Psychiatry (2015) 0.82
Age and sex as moderators of the placebo response – an evaluation of systematic reviews and meta-analyses across medicine. Gerontology (2015) 0.77
Placebo response and the company it keeps. JAMA Pediatr (2013) 0.77
Atopic diseases and inflammation of the brain in the pathogenesis of autism spectrum disorders. Transl Psychiatry (2016) 0.77
Escitalopram pharmacogenetics: CYP2C19 relationships with dosing and clinical outcomes in autism spectrum disorder. Pharmacogenet Genomics (2015) 0.75
Relationship between Long Chain n-3 Polyunsaturated Fatty Acids and Autism Spectrum Disorder: Systematic Review and Meta-Analysis of Case-Control and Randomised Controlled Trials. Nutrients (2017) 0.75
Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA (2010) 13.88
Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med (2008) 11.44
Risperidone in children with autism and serious behavioral problems. N Engl J Med (2002) 9.35
Lack of benefit of a single dose of synthetic human secretin in the treatment of autism and pervasive developmental disorder. N Engl J Med (1999) 4.63
The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects. Am J Ment Defic (1985) 4.59
Varieties of repetitive behavior in autism: comparisons to mental retardation. J Autism Dev Disord (2000) 4.17
Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. Arch Gen Psychiatry (2005) 3.36
Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism. Arch Gen Psychiatry (2009) 3.32
A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder. J Am Acad Child Adolesc Psychiatry (2009) 2.69
Efficacy of tricyclic drugs in treating child and adolescent depression: a meta-analysis. BMJ (1995) 2.61
Secretin and autism: a two-part clinical investigation. J Autism Dev Disord (2000) 2.27
Placebo response in randomized controlled trials of antidepressants for pediatric major depressive disorder. Am J Psychiatry (2008) 2.25
Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder. Pediatrics (2009) 2.13
A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. Arch Gen Psychiatry (1996) 2.04
Medication use among children with autism spectrum disorders. J Child Adolesc Psychopharmacol (2007) 1.70
Children's Yale-Brown Obsessive Compulsive Scale modified for pervasive developmental disorders. J Am Acad Child Adolesc Psychiatry (2006) 1.61
A systematic review of secretin for children with autism spectrum disorders. Pediatrics (2011) 1.60
A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders. Arch Gen Psychiatry (1998) 1.47
Predictors and moderators of treatment outcome in the Pediatric Obsessive Compulsive Treatment Study (POTS I). J Am Acad Child Adolesc Psychiatry (2010) 1.42
Improved social and language skills after secretin administration in patients with autistic spectrum disorders. J Assoc Acad Minor Phys (1998) 1.36
Atomoxetine for hyperactivity in autism spectrum disorders: placebo-controlled crossover pilot trial. J Am Acad Child Adolesc Psychiatry (2006) 1.24
Placebo response and antidepressant clinical trial outcome. J Nerv Ment Dis (2003) 1.23
Double-blind, placebo-controlled study of amantadine hydrochloride in the treatment of children with autistic disorder. J Am Acad Child Adolesc Psychiatry (2001) 1.19
A double-blind, placebo-controlled study of valproate for aggression in youth with pervasive developmental disorders. J Child Adolesc Psychopharmacol (2005) 1.16
Moderators, mediators, and other predictors of risperidone response in children with autistic disorder and irritability. J Child Adolesc Psychopharmacol (2010) 1.15
Placebo effects in developmental disabilities: implications for research and practice. Ment Retard Dev Disabil Res Rev (2005) 1.14
Risperidone in children with autism: randomized, placebo-controlled, double-blind study. J Child Neurol (2006) 1.06
Risperidone improves behavioral symptoms in children with autism in a randomized, double-blind, placebo-controlled trial. J Autism Dev Disord (2007) 1.01
Divalproex sodium vs placebo for the treatment of irritability in children and adolescents with autism spectrum disorders. Neuropsychopharmacology (2009) 1.00
Effect of secretin on children with autism: a randomized controlled trial. Dev Med Child Neurol (2000) 1.00
A randomized, double-blind, placebo-controlled trial of single-dose intravenous secretin as treatment for children with autism. J Pediatr (2001) 0.97
Predictors of placebo response in randomized controlled trials of psychotropic drugs for children and adolescents with internalizing disorders. J Child Adolesc Psychopharmacol (2010) 0.91
A double-blind placebo-controlled pilot study of olanzapine in childhood/adolescent pervasive developmental disorder. J Child Adolesc Psychopharmacol (2006) 0.88
A double-blind, placebo-controlled trial of oral human immunoglobulin for gastrointestinal dysfunction in children with autistic disorder. J Autism Dev Disord (2009) 0.87
Secretin is an ineffective treatment for pervasive developmental disabilities: a review of 15 double-blind randomized controlled trials. Res Dev Disabil (2004) 0.85
Double-blind placebo-controlled trial of secretin: effects on aberrant behavior in children with autism. J Autism Dev Disord (2002) 0.84
A controlled trial with ORG 2766, an ACTH-(4-9) analog, in 50 relatively able children with autism. Eur Neuropsychopharmacol (1996) 0.83
Multiple doses of secretin in the treatment of autism: a controlled study. Acta Paediatr (2002) 0.83
Antidepressant-placebo differences in 16 clinical trials over 10 years at a single site: role of baseline severity. Psychopharmacology (Berl) (2010) 0.81
The use of psychedelic agents with autistic schizophrenic children. Behav Neuropsychiatry (1969) 0.79
Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science (2008) 20.68
Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet (2007) 14.05
Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature (2009) 9.47
Risperidone in children with autism and serious behavioral problems. N Engl J Med (2002) 9.35
Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. Arch Intern Med (2007) 8.59
Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation (2005) 8.54
Clinical utility of different lipid measures for prediction of coronary heart disease in men and women. JAMA (2007) 6.95
Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med (2002) 6.92
Soft drink consumption and risk of developing cardiometabolic risk factors and the metabolic syndrome in middle-aged adults in the community. Circulation (2007) 6.34
Pregnancy loss rates after midtrimester amniocentesis. Obstet Gynecol (2006) 5.99
First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med (2005) 4.89
The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2006) 4.58
Comparison of hypothermia and normothermia after severe traumatic brain injury in children (Cool Kids): a phase 3, randomised controlled trial. Lancet Neurol (2013) 4.20
Association between maternal use of folic acid supplements and risk of autism spectrum disorders in children. JAMA (2013) 4.08
Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence. Hypertension (2004) 3.51
Anxiety in children and adolescents with autism spectrum disorders. Clin Psychol Rev (2009) 3.39
Effect of aging on A1C levels in individuals without diabetes: evidence from the Framingham Offspring Study and the National Health and Nutrition Examination Survey 2001-2004. Diabetes Care (2008) 3.33
Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism. Arch Gen Psychiatry (2009) 3.32
Behavior therapy for children with Tourette disorder: a randomized controlled trial. JAMA (2010) 3.28
Brain damage in preterm newborns and maternal medication: the ELGAN Study. Am J Obstet Gynecol (2012) 3.28
Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia. N Engl J Med (2014) 3.25
Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study. Am J Psychiatry (2009) 3.17
Oxytocin increases retention of social cognition in autism. Biol Psychiatry (2006) 2.94
Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology. Am J Psychiatry (2005) 2.94
Significant linkage to compulsive hoarding on chromosome 14 in families with obsessive-compulsive disorder: results from the OCD Collaborative Genetics Study. Am J Psychiatry (2007) 2.84
A replication of the Autism Diagnostic Observation Schedule (ADOS) revised algorithms. J Am Acad Child Adolesc Psychiatry (2008) 2.82
A candidate gene analysis of methylphenidate response in attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2009) 2.80
New norms for a new generation: cognitive performance in the framingham offspring cohort. Exp Aging Res (2004) 2.75
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision. World J Biol Psychiatry (2008) 2.64
Fluoxetine treatment for prevention of relapse of depression in children and adolescents: a double-blind, placebo-controlled study. J Am Acad Child Adolesc Psychiatry (2004) 2.63
Adulthood outcome of tic and obsessive-compulsive symptom severity in children with Tourette syndrome. Arch Pediatr Adolesc Med (2006) 2.62
Probing compulsive and impulsive behaviors, from animal models to endophenotypes: a narrative review. Neuropsychopharmacology (2009) 2.60
Practice guideline for the treatment of patients with obsessive-compulsive disorder. Am J Psychiatry (2007) 2.53
Maternal thyroid hypofunction and pregnancy outcome. Obstet Gynecol (2008) 2.52
Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling. Am J Psychiatry (2006) 2.50
The Preschool Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS) 6-year follow-up. J Am Acad Child Adolesc Psychiatry (2013) 2.48
Detection of clinically relevant genetic variants in autism spectrum disorder by whole-genome sequencing. Am J Hum Genet (2013) 2.47
Social skills development in children with autism spectrum disorders: a review of the intervention research. J Autism Dev Disord (2006) 2.46
Analysis of self-selection bias in a population-based cohort study of autism spectrum disorders. Paediatr Perinat Epidemiol (2013) 2.42
First-trimester septated cystic hygroma: prevalence, natural history, and pediatric outcome. Obstet Gynecol (2005) 2.40
Basal Ganglia volumes in patients with Gilles de la Tourette syndrome. Arch Gen Psychiatry (2003) 2.33
Remission after acute treatment in children and adolescents with anxiety disorders: findings from the CAMS. J Consult Clin Psychol (2011) 2.28
Challenges in evaluating psychosocial interventions for Autistic Spectrum Disorders. J Autism Dev Disord (2005) 2.23
Hypothermia and other treatment options for neonatal encephalopathy: an executive summary of the Eunice Kennedy Shriver NICHD workshop. J Pediatr (2011) 2.22
LDL Particle Number and Risk of Future Cardiovascular Disease in the Framingham Offspring Study - Implications for LDL Management. J Clin Lipidol (2007) 2.21
Social anxiety in outpatients with schizophrenia: a relevant cause of disability. Am J Psychiatry (2004) 2.18
Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder. Pediatrics (2009) 2.13
Long-term outcome of adolescent depression initially resistant to selective serotonin reuptake inhibitor treatment: a follow-up study of the TORDIA sample. J Clin Psychiatry (2011) 2.10
The neuroscience of affiliation: forging links between basic and clinical research on neuropeptides and social behavior. Horm Behav (2006) 2.10
Gene variants of brain dopamine pathways and smoking-induced dopamine release in the ventral caudate/nucleus accumbens. Arch Gen Psychiatry (2006) 2.00
Imaging biomarkers of outcome in the developing preterm brain. Lancet Neurol (2009) 2.00
Parent-rated anxiety symptoms in children with pervasive developmental disorders: frequency and association with core autism symptoms and cognitive functioning. J Abnorm Child Psychol (2007) 1.98
Striatal volume on magnetic resonance imaging and repetitive behaviors in autism. Biol Psychiatry (2005) 1.94
Design of the silent cerebral infarct transfusion (SIT) trial. Pediatr Hematol Oncol (2010) 1.87
Widespread cortical thinning is a robust anatomical marker for attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2009) 1.87
[Coronary risk estimation in Spain using a calibrated Framingham function]. Rev Esp Cardiol (2003) 1.85
The significant effect of diabetes duration on coronary heart disease mortality: the Framingham Heart Study. Diabetes Care (2004) 1.84
A randomized controlled trial to enhance antiretroviral therapy adherence in patients with a history of alcohol problems. Antivir Ther (2005) 1.82
A parallel and distributed-processing model of joint attention, social cognition and autism. Autism Res (2009) 1.80
Electrocardiographic changes in children and adolescents treated with ziprasidone: a prospective study. J Am Acad Child Adolesc Psychiatry (2005) 1.78
A double-blind placebo-controlled trial of fluoxetine for repetitive behaviors and global severity in adult autism spectrum disorders. Am J Psychiatry (2012) 1.77
Autism spectrum disorder: advances in evidence-based practice. CMAJ (2014) 1.76
Psychiatric comorbidity in adult attention deficit hyperactivity disorder: findings from multiplex families. Am J Psychiatry (2005) 1.73
Designing research studies on psychosocial interventions in autism. J Autism Dev Disord (2007) 1.73
Risperidone and adaptive behavior in children with autism. J Am Acad Child Adolesc Psychiatry (2006) 1.71
Long-term effects of risperidone in children with autism spectrum disorders: a placebo discontinuation study. J Am Acad Child Adolesc Psychiatry (2005) 1.71
Disruptive behavior in children with Tourette's syndrome: association with ADHD comorbidity, tic severity, and functional impairment. J Am Acad Child Adolesc Psychiatry (2003) 1.69
Efficacy and tolerability of second-generation antipsychotics in children and adolescents with schizophrenia. Schizophr Bull (2007) 1.69
Oxytocin selectively improves empathic accuracy. Psychol Sci (2010) 1.69
Partitioning the heritability of Tourette syndrome and obsessive compulsive disorder reveals differences in genetic architecture. PLoS Genet (2013) 1.68
Tourette syndrome: the self under siege. J Child Neurol (2006) 1.67
Validity of the autism diagnostic interview-revised. Am J Ment Retard (2006) 1.66
Mutation screening of the PTEN gene in patients with autism spectrum disorders and macrocephaly. Am J Med Genet B Neuropsychiatr Genet (2007) 1.65
Reliability and validity of the pathological gambling adaptation of the Yale-Brown Obsessive-Compulsive Scale (PG-YBOCS). J Gambl Stud (2005) 1.64
Oxytocin can hinder trust and cooperation in borderline personality disorder. Soc Cogn Affect Neurosci (2010) 1.64
A genomewide scan for loci involved in attention-deficit/hyperactivity disorder. Am J Hum Genet (2002) 1.63
AAV-mediated gene therapy for choroideremia: preclinical studies in personalized models. PLoS One (2013) 1.62
Neurocognitive outcomes in the Treatment of Early-Onset Schizophrenia Spectrum Disorders study. J Am Acad Child Adolesc Psychiatry (2012) 1.62
Children's Yale-Brown Obsessive Compulsive Scale modified for pervasive developmental disorders. J Am Acad Child Adolesc Psychiatry (2006) 1.61
SHANK1 Deletions in Males with Autism Spectrum Disorder. Am J Hum Genet (2012) 1.59
Electroencephalography correlates of spatial working memory deficits in attention-deficit/hyperactivity disorder: vigilance, encoding, and maintenance. J Neurosci (2014) 1.58
Medication and parent training in children with pervasive developmental disorders and serious behavior problems: results from a randomized clinical trial. J Am Acad Child Adolesc Psychiatry (2009) 1.55
Further development of YBOCS dimensions in the OCD Collaborative Genetics study: symptoms vs. categories. Psychiatry Res (2008) 1.54
Project TENDR: Targeting Environmental Neuro-Developmental Risks The TENDR Consensus Statement. Environ Health Perspect (2016) 1.50